Vaishnaw Akshay

CIK 00014584943 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001458494

Recent Transactions

50 trades

Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2025-05-29$29.63/sh−5,130→ 617,825 total
Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2025-05-29$30.01/sh−1,620→ 616,205 total
Award
Scholar Rock Holding Corp$SRRK
Stock Option (Right to Buy)
2025-05-02+110,067→ 110,067 total
Award
Scholar Rock Holding Corp$SRRK
Common Stock
2025-04-27+100,000→ 122,955 total
Award
Scholar Rock Holding Corp$SRRK
Common Stock
2025-04-27+500,000→ 622,955 total
Award
Scholar Rock Holding Corp$SRRK
Common Stock
2024-06-27+13,500→ 22,955 total
Award
Scholar Rock Holding Corp$SRRK
Stock Option (Right to Buy)
2024-06-27+18,000→ 18,000 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2024-05-30+25,000→ 25,000 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-04$186.39/sh−1,107→ 23,084 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-04$189.31/sh−192→ 22,774 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-04$187.37/sh−101→ 22,983 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-04$185.54/sh−1,869→ 24,191 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-04$188.40/sh−17→ 22,966 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-04$184.70/sh−771→ 26,060 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-03+5,082→ 22,972 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-03+3,859→ 26,831 total
Award
Scholar Rock Holding Corp$SRRK
Stock Option (Right to Buy)
2023-06-21+36,000→ 36,000 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2023-06-01+25,000→ 25,000 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-04-27$197.08/sh−168→ 17,890 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-04-27$195.65/sh−104→ 18,058 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-04-27$194.94/sh−1,013→ 18,162 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-04-27$193.93/sh−910→ 19,175 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-04-27$193.18/sh−197→ 20,085 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-04-26+5,312→ 20,282 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Restricted Stock Units
2023-02-27+5,790→ 5,790 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2023-02-27+11,986→ 11,986 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2023-02-10−30,913→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-02-10$216.38/sh−19,447→ 19,272 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-02-10$63.00/sh+30,913→ 53,014 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-02-10$213.13/sh−1,709→ 51,305 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-02-10$214.28/sh−2,307→ 48,998 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-02-10$215.59/sh−10,279→ 38,719 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-02-10$217.05/sh−4,302→ 14,970 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2022-12-05−2,368→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2022-12-05−1,124→ 28,876 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2022-12-05−1,587→ 30,913 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2022-12-05$226.20/sh−1,324→ 22,101 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2022-12-05$42.22/sh+2,368→ 23,425 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2022-12-05$63.00/sh+1,587→ 21,057 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2022-12-05$88.95/sh+1,124→ 19,470 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2022-08-04$189.76/sh−5,479→ 18,919 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2022-08-04$210.75/sh−198→ 18,346 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2022-08-04$210.22/sh−195→ 18,724 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2022-08-04$210.66/sh−180→ 18,544 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2022-08-03+5,083→ 16,298 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2022-08-03+3,859→ 24,398 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2022-08-03+4,241→ 20,539 total
Award
Scholar Rock Holding Corp$SRRK
Stock Option (Right to Buy)
2022-06-16+14,000→ 14,000 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2022-06-09+25,000→ 25,000 total
Award
Scholar Rock Holding Corp$SRRK
Stock Option (Right to Buy)
2022-05-26+28,000→ 28,000 total

Companies

Recent Filings

Address

300 THIRD STREET

CAMBRIDGE, MA, 02142

View on SEC.gov